Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing
- PMID: 9044857
Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing
Abstract
A high-throughput direct-differential cDNA sequencing approach was employed to identify genes differentially expressed in normal breast as compared with breast cancer. Approximately 6000 expressed sequence tags (ESTs) from cDNA libraries of normal breast and breast carcinoma were selected randomly and subjected to EST-sequencing analysis. The relative expression levels of more than 2000 unique EST groups were quantitatively compared in normal versus cancerous breast. Of many putative differentially expressed genes, a breast cancer-specific gene, BCSGC1, which was expressed in high abundance in a breast cancer cDNA library but scarcely in a normal breast cDNA library, was identified as a putative breast cancer marker. In situ hybridization analysis demonstrated stage-specific BCSG1 expression as follows: BCSG1 was undetectable in normal or benign breast lesions, showed partial expression in ductal carcinoma in situ, but was expressed at an extremely high level in advanced infiltrating breast cancer. The predicted amino acid sequence of BCSG1 gene has a significant sequence homology to the non-amyloid beta protein fragment of the Alzheimer's disease amyloid protein. BCSG1 overexpression may indicate breast cancer malignant progression from benign breast or in situ carcinoma to the highly infiltrating carcinoma.
Similar articles
-
[The effect of breast cancer specific gene 1 in the prognosis of breast cancer].Zhonghua Wai Ke Za Zhi. 2005 Mar 1;43(5):294-7. Zhonghua Wai Ke Za Zhi. 2005. PMID: 15842935 Chinese.
-
Expression of neuronal protein synuclein gamma gene as a novel marker for breast cancer prognosis.Breast Cancer Res Treat. 2007 Mar;101(3):259-67. doi: 10.1007/s10549-006-9296-7. Epub 2006 Jul 4. Breast Cancer Res Treat. 2007. PMID: 16821081
-
Breast cancer genome anatomy: correlation of morphological changes in breast carcinomas with expression of the novel gene product Di12.Oncogene. 1998 Jan 22;16(3):327-33. doi: 10.1038/sj.onc.1201517. Oncogene. 1998. PMID: 9467958
-
HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9796-801. doi: 10.1073/pnas.171138398. Epub 2001 Jul 31. Proc Natl Acad Sci U S A. 2001. PMID: 11481438 Free PMC article.
-
Silencing of BCSG1 with specific siRNA via nanocarriers for breast cancer treatment.Bull Cancer. 2021 Mar;108(3):323-332. doi: 10.1016/j.bulcan.2020.10.022. Epub 2021 Jan 8. Bull Cancer. 2021. PMID: 33423781 Review.
Cited by
-
Gamma-synuclein binds to AKT and promotes cancer cell survival and proliferation.Tumour Biol. 2016 Nov;37(11):14999-15005. doi: 10.1007/s13277-016-5371-9. Epub 2016 Sep 22. Tumour Biol. 2016. PMID: 27655287
-
ATM suppresses SATB1-induced malignant progression in breast epithelial cells.PLoS One. 2012;7(12):e51786. doi: 10.1371/journal.pone.0051786. Epub 2012 Dec 10. PLoS One. 2012. PMID: 23251624 Free PMC article.
-
Neurotoxic conversion of beta-synuclein: a novel approach to generate a transgenic mouse model of synucleinopathies?J Neurol. 2009 Aug;256 Suppl 3:286-92. doi: 10.1007/s00415-009-5246-8. J Neurol. 2009. PMID: 19711118 Review.
-
Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons.J Neurosci. 2000 May 1;20(9):3214-20. doi: 10.1523/JNEUROSCI.20-09-03214.2000. J Neurosci. 2000. PMID: 10777786 Free PMC article.
-
Fiber diffraction of synthetic alpha-synuclein filaments shows amyloid-like cross-beta conformation.Proc Natl Acad Sci U S A. 2000 Apr 25;97(9):4897-902. doi: 10.1073/pnas.97.9.4897. Proc Natl Acad Sci U S A. 2000. PMID: 10781096 Free PMC article.
Publication types
MeSH terms
Substances
Associated data
- Actions
LinkOut - more resources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous